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Background: Chromosome 22q11.2 deletion is frequently associated with conotruncal malformations and
aortic arch anomalies. This study investigated the association of chromosome 22q11.2 deletion with clinical
manifestations in four pediatric patients with persistent fifth aortic arch.
Methods: Four patients with persistent fifth aortic arch treated between July 1997 and June 2004 were included
in this retrospective study. There were two girls and two boys, aged 2 days to 11.3 years, with persistent fifth
aortic arch and cardiac conotruncal malformations. Chart recordings, plain chest films, two-dimensional
and Doppler echocardiograms, cardiac catheterization with angiograms, surgical findings, and cytogenetic
study were analyzed.
Results: Clinically, all four patients had the cardinal phenotypic features of 22q11.2 deletion syndrome,
including cardiovascular malformations (conotruncal malformations and aortic arch anomalies), abnormal
facies, thymic hypoplasia, canopy anomaly of the palate (high-arched palate, rather than cleft palate), and
hypocalcemia (or hypoparathyroidism). All four patients were confirmed to have chromosome 22q11.2
deletion.
Conclusion: Congenital conotruncal malformations, including tetralogy of Fallot with pulmonary atresia or
stenosis, and aortic arch anomalies including a persistent fifth aortic arch or a right aortic arch, should lead
to suspicion of chromosome 22q11.2 deletion when manifested together with any one of the other four
cardinal phenotypic features. [J Formos Med Assoc 2006;105(4):284–289]
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Chromosome 22q11.2 deletion is frequently as-
sociated with cardiac conotruncal malformations
and aortic arch anomalies.1,2 However, among
these cardiovascular malformations, there are
limited data on persistent fifth aortic arch as a
cardiovascular phenotype in patients with CATCH
22 (cardiovascular malformations, abnormal
facies, thymic hypoplasia, canopy anomaly of
the palate in terms of high-arched palate or cleft
palate, hypocalcemia or hypoparathyroidism, and
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chromosome 22q11 deletion). This study in-
vestigated the clinical features of CATCH 22 in
four pediatric patients with persistent fifth aortic
arch.
Methods
Four patients with aortic arch anomaly of per-
sistent fifth aortic arch and conotruncal cardiac
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blood flow from the patent ductus arteriosus,
which was documented by Doppler echocardio-
graphy on the background of tetralogy of Fallot
with pulmonary atresia, prompted intravenous
infusion of prostaglandin E1 in order to increase
pulmonary arterial blood flow, which was reduced
due to the ductal-dependent obstructive right heart
lesion. The oxygen saturation exceeded 90% after
intravenous infusion of prostaglandin E1 at a dos-
age of 30 ng/kg/min.
Emergency cardiac catheterization and angio-
graphy identified non-confluent pulmonary atresia
with severe stenosis of both branch pulmonary
arteries (3.0 mm in diameter in each), and limited
ductal flow of the patent ductus arteriosus (3.0
mm in diameter) from a relatively small persistent
fifth aortic arch (3.2 mm in diameter). The persist-
ent fifth aortic arch had a peculiar course, with take-
off very early as the first branch from the ascending
aorta, connecting proximally to the non-confluent
pulmonary artery via the patent ductus arteriosus,
and continuing distally as the left common carot-
id artery (Figure A). The left subclavian artery arose
aberrantly as the last branch from a right aortic
arch (Figure B). Creatine kinase (3409 U/L) and
its myocardial fraction (97 U/L) were highly ele-
vated. The patient died while pending surgical con-
struction of a Blalock-Taussig shunt. The abnor-
mal pattern of the aortic arch was further sketched
by hand to illustrate the branching anomalies si-
multaneously (Figure C).
Cytogenetic analysis and FISH study (Figure D)
of the proband’s blood confirmed chromosome
22q11.2 deletion, with a karyotype of 46,XY.ish
del(22)(q11.2 q11.2)(TUPLE-1). The embryo-
genesis of the aortic arch anomalies in this case
can be summarized as follows: (1) persistence of
the right-side fourth dorsal aortic artery as a right
aortic arch; (2) persistence of the retroesophageal
aortic artery in a right aortic arch as an aberrant
left subclavian artery from a right aortic arch; (3)
persistence of the left-side fifth dorsal aortic artery
as a persistent left fifth aortic arch; (4) persistence
of the left-side sixth distal aortic artery as a patent
ductus arteriosus; (5) persistence of the left third
dorsal aortic artery as a left common carotid artery;
malformations, treated between July 1997 and
June 2004, were included in this retrospective
study. Data collected from medical records in-
cluded physical manifestations, plain chest
films, two-dimensional echocardiograms with
color Doppler, cardiac catheterization with cine-
angiograms, surgical findings, and chromo-
some analysis with fluorescence in situ hybridi-
zation (FISH) study. FISH analysis was performed
using a TUPLE 1 gene (22q11.2) specific probe
(SpectrumOrangeTM Probe; Vysis Inc, Des Plaines,
IL, USA) in order to identify any deletion in this
region. The ARSA probe for the arylsulfatase A gene
(SpectrumGreenTM; Vysis Inc) was also used as an
internal control.
Illustrative case
A 2-day-old male neonate (Case 4) was transferred
from a local obstetric clinic to the intensive care
unit under the impression of cyanotic congenital
heart disease due to clinical manifestations of ap-
preciable acrocyanosis with oxygen saturation
< 60% on the peripheral pulse oximeter, tachypnea,
subcostal retraction, tachycardia, and a faint heart
murmur. He was born uneventfully at 41 weeks
of gestation by spontaneous delivery, with a birth
weight of 2.25 kg (< 10th percentile), which is con-
sidered to be small for gestational age.
On the first day in the intensive care unit, his
respiratory rate was 62 breaths/min, heart rate was
160 bpm, and blood pressure was within nor-
mal limits. Oxygen saturation was 81% on the pe-
ripheral pulse oximeter under inhalation of 30%
oxygen. Physical examination showed a small
baby for gestational age with hypertelorism, tent-
ed mouth, low-set ears, high-arched palate, and
bilateral clubfeet. On chest auscultation, there
was a single second heart sound over the left up-
per sternal border and a faint systolic murmur over
the left second intercostal space. Hemoglobin was
13 g/dL. Profiles of coagulation study and intact
parathyroid hormone were within normal limits
on the first day of hospitalization. Ionized cal-
cium was 0.63 mmol/L (normal range, 0.9–1.25
mmol/L). Plain chest film showed decreased pul-
monary vascular markings. Scanty pulmonary
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and (6) regression of the left fourth dorsal aortic
artery (absence of a left aortic arch).
Results
The clinical features of the four patients with per-
sistent fifth aortic arch and chromosome 22q11
deletion are summarized in the Table. The car-
diovascular phenotypes included the following:
tetralogy of Fallot in four; right aortic arch in four;
persistent fifth aortic arch in four; pulmonary
atresia in two; pulmonary stenosis in two; aber-
rant left subclavian artery in two; non-confluent
pulmonary artery in two; abnormal origin of the
left common carotid artery from the persistent
fifth aortic arch in two; abnormal origin of the left
subclavian artery from the persistent fifth aortic
arch in one; isolated infundibuloarterial inversion
in one; vascular ring composed of a right aortic
Figure. Illustration of abnormalities in Case 4 with persistent fifth aortic arch. (A) The ascending aortography shows early and immediate opacification of
a persistent fifth aortic arch that takes off very early as the first branch from the ascending aorta of a right aortic arch, connects proximally to the non-
confluent pulmonary artery via the patent ductus arteriosus, and continues distally as the left common carotid artery. (B) The left subclavian artery is
visualized only after the descending aorta, i.e. showing aberrant takeoff as the last branch of a right aortic arch in the ascending aortography. (C) The
branching pattern of the aortic arch is summarized: 1 = left common carotid artery; 2 = right common carotid artery; 3 = right subclavian artery; 4 =
aberrant left subclavian artery; 5 = persistent fifth aortic arch; 6 = patent ductus arteriosus. (D) Fluorescence in situ hybridization (FISH) in the proband,
using a probe from the DiGeorge syndrome deletion region, shows a karyotype of 46,XY.ish del(22)(q11.2 q11.2)(TUPLE-1). FISH analysis was
performed using the TUPLE 1 gene (22q11.2) specific probe (SpectrumOrangeTM) in order to identify any deletion in this region. The ARSA probe for the
arylsulfatase A gene (SpectrumGreenTM) was also used as an internal control. A total of 10 metaphase cells were scored and all cells had only a single
green signal for the TUPLE 1 gene, i.e. loss of the red signal, indicating a deletion at 22q11.2.
  A B C
22q11.2 LSI TUPLE 1
(SpectrumOrangeTM)
22q13 LSI ARSA (22q13.2)
(SpectrumGreenTM)
  D
22
Loss of the red signal indicates a deletion
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arch and a left ligamentum arteriosum in one;
major aorticopulmonary collateral artery in one;
and patent ductus arteriosus in one. Three pa-
tients’ persistent fifth aortic arch presented as a
systemic-to-pulmonary artery conduit, and one as
a systemic-to-systemic artery conduit.
The abnormal facies included hypertelorism
in four patients, prominent nasal bridge with nar-
row nasal alae in two, short philtrum in two, small
and tented mouth in two, and low-set ears in one.
All four patients had thymic hypoplasia silhouet-
ted as a narrow cardiac waist on plain chest film.
None of the four patients had cleft palate. Each
patient, however, had a high-arched palate form-
ing a canopy or ceiling over the oral cavity. All four
patients had hypocalcemia, and only one of them
had seizure attack. De novo chromosome 22q11
deletions were found in three patients and partial
monosomy 22q due to an unbalanced (2;22)
translocation inherited from the mother, with a
karyotype of 45,XX,der(2)t(2;22)(q37;q12.1)mat.,
was found in one patient.
Congenital chylothorax and stridor, which was
related to a vascular ring, was noted in one patient.
Bacteremia developed in one patient, cat-like cry-
ing with hoarseness in one, and small for gesta-
tional age with clubfeet in one. Two neonates died
while waiting for surgical construction of Blalock-
Case 1
11 mo
F
PFAA, TOF with PS, IIAI,
RAA, and a vascular
ring made of a RAA,
an aberrant LSCA, and
a LLA
Hypertelorism, narrow
nasal alae, long philtrum,
prominent nasal bridge
Narrow cardiac waist
High-arched palate
without a cleft
Yes
De novo
Congenital chylothorax,
stridor, bacteremia, VPI
with nasal voice, speech/
language delay, hearing
impairment, mental
retardation
Case 2
5 d
F
PFAA, TOF with PA,
RAA, PFAA with distal
continuation as LSCA,
and a MAPCA from
LSCA to non-confluent
pulmonary artery
Hypertelorism, small
tented mouth
Narrow cardiac waist
High-arched palate
without a cleft
Yes
Maternally inherited
unbalanced (2;22)
translocation
Cat-like crying,
hoarseness, sudden
cardiac death
Case 4
2 d
M
PFAA, TOF with PA, RAA,
an aberrant LSCA, and PFAA
with distal continuation
as LCCA and proximal
connection via PDA to non-
confluent pulmonary artery
Hypertelorism, small tented
mouth, low-set ears
Narrow cardiac waist
High-arched palate
without a cleft
Yes
De novo
Small for gestational age,
clubfeet, died
Case 3
11 yr 4 mo
M
PFAA, TOF with PS,
RAA, PFAA with distal
continuation as LCCA
Hypertelorism, narrow
nasal alae, long philtrum,
prominent nasal bridge
Narrow cardiac waist
High-arched palate
without a cleft
Yes
De novo
VPI with nasal voice,
speech/language delay,
hearing impairment,
mental retardation
Table. Clinical profiles of four patients with persistent fifth aortic arch and 22q11.2 deletion (CATCH 22 or 22q11.2
deletion syndrome)
Age
Gender
CATCH 22 acronym
Cardiac defects or
malformations
Abnormal facies
Thymic hypoplasia
Canopy or ceiling
anomaly of the palate*
Hypocalcemia
22q11 deletion
Annotations
*Canopy or ceiling anomaly of the palate may be a more appropriate description than cleft palate to represent the features comprising the acronym
CATCH 22. IIAI = isolated infundibuloarterial inversion; LCCA = left common carotid artery; LLA = left ligamentum arteriosum; LSCA = left subclavian
artery; MAPCA = major aortopulmonary collateral artery; PA = pulmonary atresia; PDA = patent ductus arteriosus; PFAA = persistent fifth aortic arch;
PS = pulmonary stenosis; RAA = right aortic arch; TOF = tetralogy of Fallot; VPI = velopharyngeal insufficiency.
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Taussig shunts. Two patients survived total cor-
rection of their cardiac malformations. Both of
these patients had velopharyngeal insufficiency
with nasal voice or hypernasality, speech and
language delay, hearing impairment, and mental
retardation during 5 years’ follow-up.
Discussion
The 22q11.2 deletion syndrome is frequently as-
sociated with conotruncal malformation and
aortic arch anomaly.1–13 However, there are few re-
ports of the clinical linkage of persistent fifth aor-
tic arch with chromosome 22q11.2 deletion.11,12
The 22q11.2 deletion syndrome has been report-
ed to encompass the three major syndromes of
DiGeorge syndrome (DGS), velocardiofacial syn-
drome (VCFS) and conotruncal anomaly face
syndrome (CTAFS),9,13 which affect the develop-
ment of the third and fourth branchial pouches
and manifest variable phenotypes due to migra-
tion disorder of neural crest cells.
Some complex cardiovascular defects with
22q11.2 deletion have been considered to be iso-
lated from extracardiac phenotypic expression and
assumed to represent a different subgroup, in ad-
dition to their syndromic combination with the
extracardiac features identified in patients with te-
tralogy of Fallot.3 This does not, however, account
for the high variability in the phenotypes of the
above three syndromes,9,14 and the subtle expres-
sion of extracardiac features can be overlooked or
unrecognized without scrupulous identification.14
The variable phenotypic expression may be due
to migration disorder of neural crest cells in dif-
ferent degrees and amounts.3,4,15,16 Identification of
the six characteristic phenotypes of CATCH 22
in cases of DGS, VCFS and CTAFS is not difficult,
but recognition of less characteristic phenotypes
and of the seemingly isolated complex cardio-
vascular malformations which manifest in CATCH
22 may be delayed. Cardiac defects (conotruncal
malformations and aortic arch anomalies; 100%)
and abnormal facies (or facial dysmorphy; 92%)
reminiscent of DGS, VCFS and CTAFS, which clear-
ly manifest early in life, may be considered to
be the cardinal and consistent features of CATCH
22.13,14 Hypocalcemia, thymic hypoplasia and
cleft palate were observed in 62%, 41% and 0%,
respectively, in one report of 13 patients with
CATCH 22.13 All four (100%) of our patients had
cardiac defects, abnormal facies, thymic hypopla-
sia and hypocalcemia. None of our four patients
had cleft palate, while each had a high-arched
palate. Cleft palate was often observed in VCFS,9,14
while high-arched palate is the characteristic
palatal anomaly in DGS16 and CTAFS.3 With the
collaboration of pediatric cardiologists, neonato-
logists, and dysmorphologists, 22q11.2 deletion
syndrome can be differentially diagnosed easily
by recognition of the characteristic cardiac mal-
formations and facial dysmorphism. However, the
four cases in this study suggest that canopy (or
ceiling) anomaly of the palate should be substi-
tuted for cleft palate as one of the terms forming
the CATCH 22 acronym, since cleft palate is not a
pertinent finding.
Kirby et al reported that many cardiovascular
malformations, including inflow, outflow, and
aortic arch artery anomalies, developed after re-
moval of neural crest cells in chicks.1,2 Patterning
anomaly of the aortic arch has an established clin-
ical and etiologic basis.1–8,10–13 We documented per-
sistent fifth aortic arch associated with 22q11.2
deletion in four patients, which was due to de novo
deletion in three of four patients, and to partial
monosomy caused by an unbalanced (2;22)
translocation inherited from the mother in one
patient.12 Maternal transmission of unbalanced
translocation of chromosome 22, in addition to
de novo deletion,11 may play a role in the inherited
22q11.2 deletion syndrome.12 In general, besides
maternal transmission of unbalanced trans-
location, other inheritance patterns should be
considered, such as parental origin of deletion,
since parental inherited 22q11.2 deletion was
reported to be responsible for 6–10% of cases of
22q11.2 deletion.17 Parental karyotyping as well
as FISH are, thus, recommended.
Persistent fifth aortic arch is an often ignored
and underestimated disease, and may be roughly
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included in the broad spectrum of cardiovas-
cular defects associated with 22q11.2 deletion syn-
drome.18,19 Recent studies have searched for pos-
sible candidate genes of DGS. The TBX1 gene,
harbored in a 3 Mb critical region within 22q11.2,
was thought to be a strong candidate because of
the five cardinal phenotypes of 22q11.2 deletion
syndrome.17,20 Aortic arch defects were also noted
in haploinsufficiency for Tbx1 in a mouse model
of DGS.21 Screening of the mutations in the TBX1
gene awaits further study. A cascade of molecular
biology may occur initially by gene deletion, re-
sulting in defective or abnormal migration of
the neural crest cells to the target areas, and sub-
sequent development of cardiovascular malform-
ations.11,12 Thus, persistent fifth aortic arch may
represent cardiovascular phenotypes related to
patterning anomaly of the aortic arch.
In conclusion, it is important to perform FISH
study for 22q11.2 deletion in patients with the
cardiac phenotype of persistent fifth aortic arch,
especially when any one of the extracardiac stig-
mata of 22q11.2 deletion syndrome is identified,
in that persistent fifth aortic arch could be a har-
binger of 22q11.2 deletion.
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